LOUIS, May 15 /PRNewswire/ — The Society of Gastroenterology Nurses andAssociates, Inc. These investments are focused oncommercial stage companies and products, and consist of investments in theform of royalties, revenue interests, debt and equity. Combined, the Paul CapitalHealthcare funds have invested more than $965 million in the pharmaceutical,biotechnology, and medical device sectors. “Over the past two years, Fate Therapeutics has amassed extensive intellectualproperty assets as a foundation for our adult stem cell biology engine,” saidPaul Grayson, president and CEO of Fate Therapeutics. * Amaretto (MSRP: $69.99), a traditional men`s oxford silhouette with a lace upclosure and comes in black and is available in men`s sizes 7-13.”The growing popularity of Crocs Work shoes among professionals in therestaurant, hospitality, healthcare, and foodservice industries is apparent moreso now than ever before,” said Eddie Scott, Director of Crocs ProfessionalFootwear Division. (NASDAQ:CROX) introduced three new styles to their Crocs Workcollection designed specifically for people in the restaurant, food service,healthcare, and hospitality industries. CHICAGO, Ill.–(Business Wire)–Today Crocs, Inc.

Jobscience, Inc.Michael Vicchitto, 415.354.5617 (office)Marketing Manager Business Wire 2009. Google, Google Apps, Gmail, and Google Docs are trademarks of Google Inc. About Jobscience Founded in 1999, Jobscience () has a vast portfolio ofautomated applicant tracking and management solutions that integrate all keyhiring and employee management functions through a central web interface.Automating the process tightens the workflow between HR managers, recruiters andcandidates, and ultimately decreases hiring costs. market had also reached a bottom, projecting a recovery in the latter half of 2009.”A 10 million-unit (a year) market is abnormal for the United States,” he said.

EBITDA increased 31%year-over-year to $11 Million or $0.21 per dilutive share.For more information about the conference or to schedule a one-on-onemeeting with the company, contact your Stephens institutional salesrepresentative.About Stephens Inc.Stephens is a full service investment banking firm headquartered in LittleRock, Arkansas Founded in 1933, Stephens Inc. For more information aboutBrigham Exploration, please visit our website at or contactInvestor Relations at 512-427-3444.Forward-Looking Statement DisclosureThe matters discussed in this news release are forward-looking statementswithin the meaning of the federal securities laws. In addition, Brigham anticipates drilling twoadditional two section horizontal wells to be completed with up to 24fracture stimulation stages in McKenzie County, North Dakota. Upon closure of the commonstock offering, a portion of the proceeds from the offering would be usedto increase Brigham’s 2009 capital budget to support the restart of itsoperated Williston Basin drilling program to further delineate itsacreage position in the basin. Alan Moore, President and CEO, commented as follows:”We are very pleased that the FDA has followed up their verbalconfirmation so quickly with a formal letter to lift the clinical hold,allowing us to initiate the Phase IIb clinical trial with limited delay.”About REGENESIS: NTx(R)-265 is SCT’s lead therapeutic regimen of twoapproved and clinically well-defined drugs, human Chorionic Gonadotropin(“hCG”) and Erythropoietin (“EPO”), targeting the treatment of stroke.The twin objectives of the treatment are to stimulate the growth anddifferentiation of new neurons to replace the brain cells that were lostor damaged by the stroke, and importantly, to direct motor, visual, andcognitive recovery after the acute ischemic stroke.